These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 27067620

  • 21. Left ventricular hypertrophy by Sokolow-Lyon voltage criterion predicts mortality in overweight hypertensive subjects.
    Antikainen RL, Grodzicki T, Beevers DG, Webster J, Jokelainen JJ, Bulpitt CJ.
    J Hum Hypertens; 2009 Jan; 23(1):20-6. PubMed ID: 18754020
    [Abstract] [Full Text] [Related]

  • 22. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E, De Nicola L, Gabbai FB, Chiodini P, Ravera M, Pieracci L, Marre S, Cassottana P, Lucà S, Vettoretti S, Borrelli S, Conte G, Minutolo R.
    Clin J Am Soc Nephrol; 2016 Feb 05; 11(2):271-9. PubMed ID: 26668021
    [Abstract] [Full Text] [Related]

  • 23. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN, Devereux RB, Okin PM.
    J Electrocardiol; 2014 Feb 05; 47(5):630-5. PubMed ID: 25052475
    [Abstract] [Full Text] [Related]

  • 24. Left ventricular hypertrophy by ECG versus cardiac MRI as a predictor for heart failure.
    Oseni AO, Qureshi WT, Almahmoud MF, Bertoni AG, Bluemke DA, Hundley WG, Lima JA, Herrington DM, Soliman EZ.
    Heart; 2017 Jan 01; 103(1):49-54. PubMed ID: 27486144
    [Abstract] [Full Text] [Related]

  • 25. Left ventricular hypertrophy determined by Sokolow-Lyon criteria: a different predictor in women than in men?
    Antikainen RL, Grodzicki T, Palmer AJ, Beevers DG, Webster J, Bulpitt CJ, Department of Health and Social Security Hypertension Care Computer Project (DHCCP).
    J Hum Hypertens; 2006 Jun 01; 20(6):451-9. PubMed ID: 16708082
    [Abstract] [Full Text] [Related]

  • 26. Additional impact of electrocardiographic over echocardiographic diagnosis of left ventricular hypertrophy for predicting the risk of ischemic stroke.
    Kohsaka S, Sciacca RR, Sugioka K, Sacco RL, Homma S, Di Tullio MR.
    Am Heart J; 2005 Jan 01; 149(1):181-6. PubMed ID: 15660051
    [Abstract] [Full Text] [Related]

  • 27. Cohort Study of ECG Left Ventricular Hypertrophy Trajectories: Ethnic Disparities, Associations With Cardiovascular Outcomes, and Clinical Utility.
    Iribarren C, Round AD, Lu M, Okin PM, McNulty EJ.
    J Am Heart Assoc; 2017 Oct 05; 6(10):. PubMed ID: 28982671
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Association of African Ancestry With Electrocardiographic Voltage and Concentric Left Ventricular Hypertrophy: The Dallas Heart Study.
    Alame AJ, Garg S, Kozlitina J, Ayers C, Peshock RM, Matulevicius SA, Drazner MH.
    JAMA Cardiol; 2018 Dec 01; 3(12):1167-1173. PubMed ID: 30427995
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Interrelations Between Hypertension and Electrocardiographic Left Ventricular Hypertrophy and Their Associations With Cardiovascular Mortality.
    Cao X, Broughton ST, Waits GS, Nguyen T, Li Y, Soliman EZ.
    Am J Cardiol; 2019 Jan 15; 123(2):274-283. PubMed ID: 30390988
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension.
    Salles GF, Cardoso CR, Fiszman R, Muxfeldt ES.
    Am Heart J; 2010 May 15; 159(5):833-40. PubMed ID: 20435193
    [Abstract] [Full Text] [Related]

  • 38. Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy on Cardiovascular Risk in a Non-Hypertensive Community-Based Population.
    Tanaka K, Tanaka F, Onoda T, Tanno K, Ohsawa M, Sakata K, Omama S, Ogasawara K, Ishibashi Y, Itai K, Kuribayashi T, Okayama A, Nakamura M, Iwate-Kenco Study Group.
    Am J Hypertens; 2018 Jul 16; 31(8):895-901. PubMed ID: 29659657
    [Abstract] [Full Text] [Related]

  • 39. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlöf B, LIFE Study Investigators.
    JAMA; 2004 Nov 17; 292(19):2343-9. PubMed ID: 15547161
    [Abstract] [Full Text] [Related]

  • 40. Interrelation Between Electrocardiographic Left Atrial Abnormality, Left Ventricular Hypertrophy, and Mortality in Participants With Hypertension.
    Ahmad MI, Mujtaba M, Anees MA, Li Y, Soliman EZ.
    Am J Cardiol; 2019 Sep 15; 124(6):886-891. PubMed ID: 31324356
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.